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Voltage-gated potassium currents (Kv), primar-
ily due to Kv2.1 channels, are activated by
glucose-stimulated pancreatic b cell depolar-
ization, but the exact role (or roles) of this chan-
nel in regulating insulin secretion remains
uncertain. Here we report that, compared with
controls, Kv2.1 null mice have reduced fasting
blood glucose levels and elevated serum insulin
levels. Glucose tolerance is improved and insu-
lin secretion is enhanced compared to control
animals, with similar results in isolated islets
in vitro. Isolated Kv2.1/ b cells have residual
Kv currents, which are decreased by 83%
at +50 mV compared with control cells. The glu-
cose-induced action potential (AP) duration is
increased while the firing frequency is dimin-
ished, similar to the effect of specific toxins on
control cells but substantially different from
the effect of the less specific blocker tetraethy-
lammonium. These results reveal the specific
role of Kv2.1 in modulating glucose-stimulated
APs of b cells, exposing additional important
currents involved in regulating physiological
insulin secretion.
INTRODUCTION
Glucose homeostasis is maintained through coordinated
metabolic, hormonal, and neural signals. These signals re-
sult in the tightly regulated release of insulin and glucagon.
Glucose-induced ion fluxes in the pancreatic b cell are
critical for normal glucose homeostasis (Rorsman et al.,
1994). Pancreatic b cells metabolize glucose, generating
an increase in the ATP:ADP ratio that closes the ATP-sen-
sitive potassium channel, KATP, resulting in membrane de-
polarization, calcium influx, and insulin release (Ashcroft
and Rorsman, 1989). Glucose-induced depolarization of
the b cell activates voltage-gated channels, including theCell Medelayed-rectifier potassium channel Kv2.1. The resulting
outward K+ current in turn controls the duration of depo-
larization and thus can affect insulin exocytosis (Rorsman
and Trube, 1986; Smith et al., 1990; Dukes and Philipson,
1996; Philipson et al., 1994; MacDonald et al., 2001; Yan
et al., 2004; Herrington et al., 2005).
Kv2.1 is sensitive to a variety of pharmacological
agents. These include highly specific agents such as
the cysteine-knot spider venoms hanatoxin (HaTx) and
stromatoxin (ScTx) and others that are less specific,
such as tetraethylammonium (TEA) and 4-aminopyridine
(Swartz and MacKinnon, 1995; Escoubas et al., 2002;
Atwater et al., 1979; Bokvist et al., 1990; Kirsch and
Drewe, 1993). Our current understanding of the role of
Kv channels in islet physiology has been generated pri-
marily through pharmacological approaches using these
agents. Kv channel blockade increases both the ampli-
tude and duration of b cell action potentials (APs)
(MacDonald et al., 2002a; Tamarina et al., 2005;
Herrington et al., 2006). Augmentation of the b cell AP
also leads to changes in glucose-induced calcium fluc-
tuations, leading to elevated islet insulin secretion
(MacDonald et al., 2002a; Tamarina et al., 2005;
Herrington et al., 2006). These results have also been
corroborated with a dominant-negative Kv construct
that reduces Kv2.1 functional expression and enhances
glucose-stimulated insulin secretion (GSIS) in an insuli-
noma cell line (MacDonald et al., 2001). However, the
role (or roles) of Kv2.1 in b cell physiology in vivo has
not been conclusively defined.
Here, we investigated the physiological role of Kv2.1 in
b cells from amousemodel in which the Kv2.1 gene is dis-
rupted. We found that the b cells from these null animals
have greatly reduced Kv currents, indicating that Kv2.1
is indeed the primary Kv channel of the b cell. Action po-
tentials are widened compared with controls, while the
frequency of APs is reduced. Kv2.1 null mice also show
significantly reduced fasting glucose levels and elevated
insulin levels. These studies reveal the relationship be-
tween Kv channels, AP regulation, and insulin secretion.
The lack of Kv2.1 exposes additional important b cell
currents and suggests that plasma membrane electrical
activity regulates physiological insulin secretion.tabolism 6, 229–235, September 2007 ª2007 Elsevier Inc. 229
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To investigate the physiological role of Kv2.1 during GSIS,
a mouse model was utilized in which the Kv2.1 gene was
disrupted at codon 346 (Figure 1A). The targeting cassette
removed 102 bases in S5 of the Kv2.1 coding sequence
and added nearly 7 kb of extraneous sequence, including
a premature stop codon 12 codons from the fusion with
Kv2.1 (Figure 1A). The disrupted gene had no significant
effect on islet cell viability as assessed by the ratio of cas-
pase-3 cleavage-positive cells to total islet cells (see
Figure S1 in the Supplemental Data available with this
article online, n = 7). Genomic DNA from homozygous
targeted animals (Kv2.1/) contained the targeting se-
quences. The disrupted sequence was detected using
PCR to produce an amplicon with one primer inside of
the targeting sequence in combination with a Kv2.1-
specific primer in the reverse orientation (30/50;
Figure 1B). Similarly, a Southern blot performed on
EcoRV-digested genomic DNA prepared with a Kv2.1-
specific probe using DNA from appropriately targeted em-
bryonic stem (ES) cell lines produced an additional 6.6 kb
fragment not present in controls (Figure 1C). Kv2.1 protein
was detected only in protein blots from wild-type tissue
preparations using a Kv2.1-specific antibody that inter-
acts with the C terminus of the protein (Figure 1D).
Kv2.1/ islet b cell size and insulin staining as well as
a cell size and glucagon staining were equivalent to con-
trols (Figure S2, n = 5 each).
Kv2.1/ animals were assessed for possible impair-
ment in glucose homeostasis using an intraperitoneal
(i.p.) glucose tolerance test. Kv2.1/ animals had signifi-
cantly decreased fasting blood glucose levels and
showed improved glucose tolerance when compared to
control animals (Figure 1E, n = 10 per group). This mild hy-
poglycemia likely resulted from a significant elevation in
the fasting serum insulin level in the Kv2.1/ animals as
compared to controls (Figure 1E inset, n = 10). Serum in-
sulin levels were not significantly different between control
and Kv2.1/ animals at 10 and 20min following a glucose
load, attributable to the reduced fasting glucose levels of
Kv2.1/ animals (Figure 1E inset, n = 10). Accordingly,
Kv2.1/ animals had glucose levels similar to controls
at 20 min post glucose loading, although they showed
an accelerated return to baseline glucose levels
(Figure 1E, n = 10).
To determine the role of islet insulin secretion in the de-
fects seen in glucose homeostasis, insulin release from
Kv2.1/ and control islets was assessed (Figure 1F).
Modest glucose stimulation (7 mM) caused a significant
elevation in the insulin peak, which was sustained for
over 20 min in the Kv2.1/ islets compared to controls
(Figure 1F, n = 10 sets of islets assayed in 3 independent
groups). Since inhibition of Kv2.1 channel activity with TEA
has been shown to increase GSIS (Henquin, 1977), insulin
release from Kv2.1/ and control islets stimulated with
TEA and glucose was measured. Quite unexpectedly,
control and Kv2.1 null islets showed augmented electrical
activity with TEA stimulation, which resulted in equivalent230 Cell Metabolism 6, 229–235, September 2007 ª2007 Elsevinsulin secretion from both groups of islets (Figure S3;
data not shown). This indicates that channels other than
Kv2.1, which are presumably permeable to potassium,
are sensitive to TEA and play a critical role in repolarization
following glucose stimulation.
Voltage-Gated Potassium Currents from Kv2.1/
Islet b Cells
Kv channels other than Kv2.1 may participate in b cell re-
polarization (Roe et al., 1996; Yan et al., 2004; MacDonald
et al., 2001; Kukuljan et al., 1991). To confirm the presence
of endogenous Kv channels in addition to Kv2.1, Kv cur-
rents from islet b cells devoid of Kv2.1 were recorded us-
ing the whole-cell voltage-clamp configuration. Kv2.1/
b cells do indeed show Kv currents; however, these cur-
rents have significantly reduced amplitudes at voltage
steps greater than 30 mV when compared to control
b cells. At 50 mV, the Kv2.1/ b cells have current ampli-
tudes that are only 17% that of controls (recorded
between 400–450 ms during a 500 ms step to 50 mV).
Pharmacological inhibition of Kv2.1 with cysteine-knot-
containing spider venom peptides such as HaTx and
ScTx-1 caused similar reductions in Kv currents in control
b cells, similar to that seen with the untreated Kv2.1/
b cells, whereas the toxins had no significant effect on
the Kv currents in Kv2.1/ b cells (Figure 2E). Of the re-
maining Kv currents from Kv2.1/ b cells, only 53% are
sensitive to block by TEA (n = 6 cells performedwith a volt-
age step from 80 to 0 mV treated with 20 mM TEA)
(Gopel et al., 2000). Thus, the channels responsible for
the remaining Kv currents of Kv2.1/ b cells are not
from the Kv2 family and may provide some repolarizing
influence on the b cell during GSIS.
Kv2.1 Regulation of the b Cell Action Potential
Kv2.1 channels have been implicated in the regulation of
glucose-stimulated AP duration through their repolarizing
influence, primarily using pharmacological approaches
(Atwater et al., 1979; MacDonald et al., 2002a; Tamarina
et al., 2005; Herrington et al., 2006). To test the role of
Kv2.1 in glucose-stimulated APs, intact islet b cell mem-
brane potentials were recorded using the perforated-
patch current-clamp configuration and stimulated with
glucose. Glucose-stimulated APs recorded from Kv2.1/
islets showed a significantly increased duration (325.4
ms/AP versus 86.7 ms/AP for control islets, p < 0.0001,
n = 7 each; Figure S4) with a greatly reduced firing fre-
quency (2/s versus 4.72/s for control islets, p < 0.0001,
n = 7 each; Figure S4) when compared to control islets
at high concentrations (14.4 mM) as well as at physiolog-
ically normal concentrations (6.5mM)of glucose (Figure 3).
Interestingly, ScTx-1 block of Kv2.1 caused the control
glucose-stimulated AP duration to increase with an asso-
ciated reduction in AP firing frequency, which resembled
glucose-treated Kv2.1/ islet APs (Figure 4). Islet calcium
fluctuations recorded following depolarization, induced
with tolbutamide to inhibit KATP, showed a similar profile
with significantly elevated amplitudes (1.9-fold ± 0.3-fold
increase in amplitude, n = 5) in response to 25 nMier Inc.
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Aberrant Glucose Homeostasis
(A) Cartoon of the Kv2.1 targeted gene disrup-
tion and the resulting disrupted protein struc-
ture in gray versus wild-type (WT) in black.
(B) PCR products from homozygous knockout
(/), heterozygous (+/), and control (+/+)
animals with primers specific to the surround-
ing Kv2.1 gene disruption sequence and one
primer specific to the targeting sequence.
(C) Southern blot probed with a Kv2.1-specific
probe run with genomic DNA from control (+/+)
and targeted (+/) embryonic stem cells cut
with an endonuclease that removes part of
theKv2.1 sequence and the targeting cassette.
(D)Western blot runwithKv2.1/ brain extracts
(lanes 1–4), control brain extracts (lanes 5–7),
Kv2.1/ islets (lane8), and control islets (lane9).
(E) Glucose tolerance test onKv2.1/ (gray line)
and control (black line) animals. Serum insulin
levels fromKv2.1/ (gray line) andcontrol (black
line) animals are shown in the inset. n = 10 each,
*p < 0.05. Error bars represent ±SD.
(F) Islet insulin secretion during 7 mM glucose
treatment (underbox); the isletswere in2mMglu-
cose previous to stimulation. n = 10 islet sets and
3 insulin assays each. Error bars represent +SD.ScTx-1. The changes in calcium dynamics of control islets
in response to Kv2.1 inhibition likely represent an
increased depolarizing influence of each AP resulting in
activation of voltage-dependent calcium channels and in-
creased calcium influx (Figures 4C and 4D). As expected,
ScTx-1 had only minimal effects on Kv2.1/ islet electri-
cal activity and calcium fluctuations (1.2-fold ± 0.04-fold
increase in amplitude, n = 5); thus, the difference in ampli-
tudes between control and Kv2.1/ islets was significant
(Figure 4; p < 0.035).
DISCUSSION
Pancreatic islet b cells respond to elevations in glucose
with an orchestrated cascade of ion-channel inhibition
and activation (Ashcroft and Rorsman, 1989; HouamedCell Met al., 2004). KATP channels are inhibited following glucose
metabolism, allowing an inward cation current to depolar-
ize the b cell, activating voltage-dependent cation chan-
nels (Ashcroft and Rorsman, 1989). This activity results in
membrane potential fluctuations, causing entry of calcium
that facilitates granule-membrane interactions culminating
in insulin secretion. Following glucose-induced depolar-
ization, rodentbcells begin to repolarize throughactivation
of voltage-gated K+ channels, especially Kv2.1 (Smith
et al., 1990; Roe et al., 1996; Yan et al., 2004; MacDonald
et al., 2001; Kukuljan et al., 1991). Indeed, human b cells
also express Kv2.1 protein, resulting in hanatoxin-sensi-
tive delayed-rectifier currents that comprise 65%of the to-
tal Kv current recorded from these cells (MacDonald et al.,
2002b; Tamarina et al., 2005; Herrington et al., 2005). The
results presented here demonstrate the effects of Kv2.1Figure 2. Kv2.1/ b Cells Have Signifi-
cantly Reduced Kv Currents
(A) Control b cell Kv currents recorded in volt-
age clamp mode with voltage steps from 80
to +80 in 10 mV increments.
(B) Control b cell Kv currents 10 min post 100
nM HaTx.
(C) Control b cell Kv currents 10 min post 100
nM ScTx-1.
(D) Kv2.1/ b cell Kv currents.
(E) Current density versus voltage plots for
b cells recorded in steps from 80 mV to the
indicated voltage (n > 7 for each condition).
Error bars represent ±SD.etabolism 6, 229–235, September 2007 ª2007 Elsevier Inc. 231
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Kv2.1 Ablation Alters Glucose HomeostasisFigure 3. Kv2.1/ Islets Have Increased
Glucose-Induced Action Potential Dura-
tion with Decreased Frequency
(A) Control islet electrical activity in response to
14 mM glucose. Inset shows the action poten-
tials (APs) from the segment of activity indi-
cated by the horizontal gray bar.
(B) Kv2.1/ islet electrical activity in response
to 14 mM glucose. Inset shows the APs from
the segment of activity indicated by the hori-
zontal gray bar.
(C) Control islet electrical activity in response to
6.5 mM glucose. Inset shows the APs from the
segment of activity indicated by the horizontal
gray bar.
(D) Kv2.1/ islet electrical activity in response
to 6.5 mM glucose. Inset shows the APs from
the segment of activity indicated by the hori-
zontal gray bar.removal on electrical activity and insulin secretion in
a mouse model with targeted ablation of the Kv2.1 gene.
The results suggest that the most prominent effects of
Kv2.1 are on the AP itself. Kv2.1 null animals show im-
proved glucose tolerance with reduced fasting glucose,
increased fasting serum insulin, and an accelerated return
to baseline following glucose challenge when compared
to control animals. Electrical activity is also perturbed in
the Kv2.1/ islets and b cells, as the remaining Kv cur-
rents show significantly reduced amplitudes at voltages
above 30 mV compared to controls. Thus, there is no
significant compensation for the loss of Kv2.1 current.
The absence of Kv2.1 current results in increased glucose-
stimulatedAPduration and, importantly, adecreasedfiring
frequency in islets and individual b cells. Interestingly,
Kv2.1 null islets still respond to TEA (10–20 mM) with
prolonged AP duration, decreased firing frequency, and
a significant increase in AP amplitude. Our studies on
Kv2.1 null islets have therefore elucidated specific modu-
latory roles for Kv2.1 in glucose-stimulated electrical activ-
ity of the b cell and suggest that yet other channels are
likely to underlie TEA-induced amplification of GSIS.
The remaining Kv current observed in Kv2.1/ b cells is
activated during glucose-stimulated islet electrical activity
and thus may help modulate insulin secretion. As the
residual b cell Kv current is sensitive to TEA, it may be par-
tially responsible for the TEA amplification of glucose-
induced AP amplitude and the resulting augmentation of
insulin secretion. Of the TEA-sensitive potassium chan-
nels expressed in pancreatic b cells other than Kv2.1,
including Kv3.2, large-conductance calcium-activated
potassium channels (BK), and intermediate-conductance
calcium-activated potassium channels (IK), the current
most closely resembles the biophysical properties of
Kv3.2 currents (Betsholtz et al., 1990; Bokvist et al.,232 Cell Metabolism 6, 229–235, September 2007 ª2007 Elsev1990; Kukuljan et al., 1991; Kirsch and Drewe, 1993;
Roe et al., 1996; Philipson, 1999; Gopel et al. 2000; Su
et al., 2001; MacDonald et al., 2001; Yan et al., 2004).
However, the residual b cell Kv current is insensitive to in-
hibitors specific to BK, IK, and Kv3.2 channels as well as
to Kv1, Kv4, and voltage-gated subfamily H (eag-related)
member 2. The molecular identity of the residual b cell
Kv current remains undefined and might be a function of
heteromeric assembly of Kv subunits. The activity of the
remaining outward current is observed at voltages that
an islet typically reaches during glucose-induced depolar-
ization, thus implicating an important role for this channel
during insulin secretion.
Pharmacological inhibition of Kv2.1 potently amplifies
GSIS (MacDonald et al., 2002a; Herrington et al., 2006;
Herrington, 2007). Interestingly, however, Kv2.1/ islets
stimulated with 14 mM glucose have an initial insulin peak
that is only slightly elevated compared to control islets,
with an accelerated rise to peak. This indicates that the in-
hibitors of Kv2.1 may not be completely specific, such as
with TEA, or that the Kv2.1/ mouse b cell might be com-
pensating for the lossofKv2.1with increased activity or ex-
pression of another channel. There is no compensation
from a Kv channel, as the amount of Kv current recorded
fromKv2.1/ b cells is equivalent to control b cells treated
with Kv2.1 inhibitors. However, this does not rule out the
possibility of another type of potassium channel, such as
a calcium-activated potassium channel, functionally com-
pensating for the Kv2.1 deficiency. The results suggest
that under physiological concentrations of glucose, such
as between meals, Kv2.1 exerts an important repolarizing
role that cannot be compensated for and, when absent,
results in significantly amplified insulin secretion.
Maintenance of baseline blood glucose levels requires
tightly regulated insulin release from the pancreatic islets.ier Inc.
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Kv2.1 Ablation Alters Glucose HomeostasisFigure 4. Control Islets Treated with ScTx-1 Show Bursting Similar to Untreated Kv2.1/ Islets
(A) Control islet electrical activity recorded continuously during treatments with 14 mM glucose alone and in combination with 100 nM ScTx-1 (black
bar). Insets show islet APs expanded during 14 mM glucose alone or in combination with 100 nM ScTx-1 treatment.
(B) Kv2.1/ islet electrical activity recorded continuously during treatments with 14mM glucose alone and in combination with 100 nM ScTx-1 (black
bar). Insets show islet APs expanded during 14 mM glucose alone or in combination with 100 nM ScTx-1 treatment.
(C–F) Representative fast-acquisition calcium traces recorded with mouse islets loaded with Fluo-4 and incubated with 200 mM tolbutamide in 2 mM
glucose from control (C) and Kv2.1/ (D) animals and from the same control (E) and Kv2.1/ (F) islets 4 min post 25 nM ScTx-1.Baseline blood glucose between meals is modulated in
part by small amounts of insulin secretion likely resulting
from small bursts of islet electrical activity (Dean and
Matthews, 1970; Beigelman et al., 1976). The data pre-
sented here suggest a novel role of Kv2.1 in regulating
fasting blood sugar by determining AP duration and
frequency, such as during the bursts of insulin secretion
between meals. The reduced fasting glucose levels of
Kv2.1/ animals apparently result from longer AP dura-
tions during the small bursts of electrical activity and
resulting increased insulin secretion.
Voltage-gated potassium channel mutations result in
a variety of pathological conditions, such as Long QT syn-
drome (Shieh et al., 2000; Zhou et al., 1998). To date, how-
ever, there have been no reports of human Kv2.1 muta-
tions, which may be due to a lack of insight into the
expected phenotype due to lack of this channel, and
heterozygous channel loss may have particularly subtle
effects. Fasting hypoglycemia in humans has many etiol-
ogies, including potassium channel mutations, one of
which could possibly result from mutations in the Kv2.1
gene (Ahn et al., 2007; Nestorowicz et al., 1996). These
studies also suggest that the repolarization of the b cell
is far more complex than previously appreciated and
involves channels in addition to Kv2.1. This includes
both TEA-sensitive and -insensitive currents present inCell Methe Kv2.1 null islets that govern AP amplitude. Our results
show that the role of Kv2.1 clearly lies in the regulation of
AP duration and frequency so that there is increased fast-
ing insulin secretion.
EXPERIMENTAL PROCEDURES
Mouse Kv2.1 Genomic Disruption
A targeting construct was designed with a 50 fragment (2623 bp) of the
genomicKv2.1 sequence (accession numberM64228) through the first
base of codon 346, inserted upstream of an IRES-lacZ-neo cassette
and followed by a 30 fragment (2457 bp) of the Kv2.1 genomic se-
quence from the first base of codon 380. The targeting construct
was electroporated into mouse ES cells, resulting in homologous
recombination between it and theKv2.1 gene sequence, causing a dis-
ruption of the Kv2.1 gene sequence at codon 346. Southern blot anal-
ysis was performed to isolate correctly targeted ES cells. ES cell geno-
mic DNA was digested with the restriction endonuclease EcoRV,
which cleaves a 23.1 kb fragment from control C57BL/6 mice contain-
ing the Kv2.1 sequence and also within the targeting cassette.
Digested genomic DNA was run on an agarose gel transferred to a ni-
trocellulose membrane and probed with a 32P-labeled Kv2.1-specific
genomic probe located inside the EcoRV fragment. Correctly targeted
ES cells show the 23.1 kb fragment from the wild-type allele as well as
a 6.6 kb fragment from the targeted allele. One of the correctly targeted
ES cell clones was injected into C57BL/6 blastocysts, giving rise to
chimeric offspring; the targeted allele was transmitted in crosses
to C57BL/6 females. These mice were created by Deltagen, Inc. Alltabolism 6, 229–235, September 2007 ª2007 Elsevier Inc. 233
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Chicago Institutional Animal Care and Use Committee.
Western Blot Analysis
Protein extracts were prepared frommouse brain and HEK cells by ex-
traction with SDS loading buffer (1% SDS, 30 mmol/l Tris-HCl [pH 6.8],
5% b-mercaptoethanol, 5%glycerol, and 0.1%bromophenol blue) and
heating at 70C for 10min. Proteins were prepared as a western blot on
a polyvinylidene fluoride membrane (Whatman). After electrophoresis
through a 14%denaturing polyacrylamidegel, anti-Kv2.1 antibody (Up-
state Biotechnology) was used to probe themembrane at 1:250 dilution
in PBS, 0.1% Tween, and 3% powdered dried milk followed by goat
anti-rabbit horseradish peroxidase (HRP)-coupled secondary antibody
(Santa Cruz Biotechnology) at 1:5000 in the same solution. The mem-
branes were washed in PBS containing 0.1%Tween between and after
antibody incubations; HRP was illuminated using Pico Signal (Pierce)
and exposed on Kodak X-Omat Blue film.
Glucose and Insulin Homeostasis
We used ten control and ten Kv2.1/ female animals for i.p. glucose
tolerance tests (Zhou et al., 2000). After a 4 hr fast, animals received
i.p. glucose (2mg/g bodyweight dextrose in PBS), and tail whole blood
samples were taken at the indicated time intervals. Blood glucose was
measured using a FreeStyle blood glucose meter (Abbott). Serum in-
sulin was measured by enzyme-linked immunosorbent assay (ELISA)
(ALPCO Diagnostics).
Islet Immunofluorescence Staining
Pancreas cubes from Kv2.1/ and C57BL/6 animals were frozen in
OCT compound (Fisher Scientific) and cut into 10 mMsections on a cry-
otome (Leica) and fixed in 2% paraformaldehyde. Islet b and a cells
were stained as described (Zhou et al., 2000) using insulin and gluca-
gon antibodies at 1:300 in combination with fluorescein isothiocya-
nate-conjugated secondary antibodies together with TO-PRO-3 iodide
nuclear stain (Invitrogen). Apoptosis was assessed using an antibody
specific to cleaved caspase-3 (Cell Signaling) in combination with
a fluorescein isothiocyanate-conjugated secondary antibody and
TO-PRO-3 iodide nuclear stain on islets stuck to coverslips and incu-
bated for 4 days as described below.
Mouse Islet and b Cell Isolation
Islets were isolated from pancreata of 1- to 5-month-old C57BL/6wild-
type mice (The Jackson Laboratory) using collagenase digestion and
Ficoll gradients as previously described (Philipson et al., 1994). Islets
were dissociated in 0.005% trypsin, placed on glass coverslips, and
cultured for 16 hr in RPMI-1640 medium supplemented with 10%
FCS, concentrations of glucose specified in the figure legends, 100
IU/ml penicillin, and 100 mg/ml streptomycin. Cells and islets were
maintained in a humidified incubator at 37C under an atmosphere
of 95% air/5% CO2.
Hormone Secretion Measurements
Mouse islets were allowed to recover following isolation for 4 hr. For
insulin measurements, 20 islets/animal (n = 5 animals per group,
Figure S3; n = 10 animals per group, Figure 1F) were perifused with
Krebs-Ringer buffer (KRB) solution containing 2 mM glucose for 15
min followed by KRBwith 7mMglucose for the remainder of the exper-
iment. Collected perfusate (1 ml/min) was analyzed for insulin content
using an ELISA-based detection kit (ALPCODiagnostics), and data are
presented as ±SD.
Electrophysiological Recordings
Whole-Cell Ruptured-Patch Recording
Voltage-activated currents were recorded using whole-cell ruptured-
patch clamps with an Axopatch 200B amplifier and pCLAMP software
(Molecular Devices). Patch electrodes (2 to 4 MU) were loaded with in-
tracellular solution containing (in mmol/l) 140 KCl, 1 MgCl2[H2O]6, 10
EGTA, 10 HEPES, 5 MgATP (pH 7.25) with KOH. Islets were perfused234 Cell Metabolism 6, 229–235, September 2007 ª2007 Elsewith KRB containing (in mmol/l) 119 NaCl, 2 CaCl2[(H2O)6], 4.7 KCl, 10
HEPES, 1.2 MgSO4, 1.2 KH2PO4, 14.4 glucose adjusted to pH 7.3 with
NaOH. In some cases, current was used to induce APs with an 80 pA 5
ms step, and the resulting voltages representing a stimulated AP were
recorded. When indicated, cells were treated with 100 nM ScTx-1
(Alomone Labs).
Islet Perforated-Patch Recording
Patch electrodes (2 to 4 MU) were loaded with intracellular solution
containing (in mmol/l) 140 KCl, 1 MgCl2[H2O]6, 10 EGTA, 10 HEPES
(pH 7.25) with KOH containing the pore-forming antibiotic amphoteri-
cin B (Rae et al., 1991) (Sigma). Islets were perfused with KRB contain-
ing (in mmol/l) 119 NaCl, 2 CaCl2[(H2O)6], 4.7 KCl, 10 HEPES, 1.2
MgSO4, 1.2 KH2PO4, and glucose as indicated, adjusted to pH 7.3
with NaOH. Cells on the periphery of islets on glass coverslips were
sealed in voltage clamp at80V while the amphotericin allowed perfo-
ration and good access over several minutes. After switching to cur-
rent clamp, cells that had a resting membrane voltage near 65V
were assumed to be b cells, the glucose-containing solution (at
37C) was perfused into a heated chamber (at 37C), and TEA
(15 mM) or ScTx-1 (100 nM) was added.
Slow-Speed Intracellular Calcium Imaging
Mouse islets attached to glass-bottom Matek tissue culture dishes
were loaded with 5 mM Fura-2 AM loaded in Krebs-Ringer-Henseleit
2 (KRH2) buffer for 30min at 37C. Loaded islets were placed in a tem-
perature controller (TC-202, Medical Systems Corp.) mounted on the
stage of an inverted microscope (Nikon TE2000) for imaging, and im-
ages were acquired at 5 s intervals. Experiments were performed
with constant perfusion with KRH2 and treated with 200 mM tolbuta-
mide in combination with 5, 10, or 15 mM TEA.
High-Speed Intracellular Calcium Imaging
Mouse islets attached to glass-bottom Matek tissue culture dishes
were loaded with 5 mM Fluo-4 AM loaded in KRH2 for 45 min at 37C.
Loaded isletswere placed in a temperature controller (TC-202,Medical
Systems Corp.) mounted on the stage of an inverted microscope
(Olympus IX70) for imaging. Experiments were performed at 37C in
static conditions. Confocal imagingwas performedwith a custom-built
systembasedonaYokogawaCSU10 spinning disk confocal unit. Islets
were excited with the 488 nm line of an Ar/Kr laser (Series 43, Omni-
chrome), and the emitted light was filtered with a 535/40 filter (Chroma)
and recorded with CoolSNAPHQ digital camera (Roper Scientific). Ac-
quisition was controlled with MetaMorph software (Universal Imaging).
In all experiments, to obtain data with sufficiently high time resolution,
we used 10 frames per second stream acquisitionmode. Data analysis
was performed with MetaMorph and Microsoft Excel.
Supplemental Data
Supplemental Data include four figures and can be found with this
article online at http://www.cellmetabolism.org/cgi/content/full/6/3/
229/DC1/.
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